IP Library Granted Patent US 7,776,219
Granted Patent B2
US 7,776,219 · App. 12/015,420 · Granted Aug 17, 2010

Methods, devices, and systems for hemodilution

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,776,219
App. No.
12/015,420
Granted
Aug 17, 2010
Kind
B2
Abstract

Devices, methods, and system that prevent clotting of blood during blood-processing procedures such as hemofiltration, hemodialysis, and hemodiafiltration are described. A filter with a cap has a housing that is shaped to receive a blood filter. The housing has an inlet for blood and may have an outlet for waste and ultrafiltrate. The cap is attached to the housing. The cap has an outlet for blood and a port adjacent the outlet for receiving dilution fluid. Methods of use during blood-processing procedures to provide immediate hemodilution to blood exiting entering and/or exiting a filter are also described.

Claims (13)

1. A method for filtering blood, comprising:

providing an extracorporeal blood filter, the filter comprising a housing having an interior volume separated by filter media into a non-blood part and blood part; the housing including a cap that defines a headspace, between the filter media and the cap, in fluid communication with the blood part; the cap having a blood port configured for attachment to external tubing for blood supply between the extracorporeal blood filter and an external blood supply line and a dilution fluid port, through which dilution fluid flows, opening directly to the headspace such that these ports are connected only through the headspace; and at least one port connected to the non-blood part;

flowing blood through the blood part while simultaneously flowing blood in the headspace, flowing blood through the blood port, and flowing dilution fluid through the dilution fluid port into the headspace, such that dilution fluid is mixed with blood in the headspace.

2. The method of claim 1 , wherein the flowing blood in the headspace includes flowing blood from the blood port into the headspace and the flowing dilution fluid in the headspace is effective to predilute blood passing into the blood part.

3. The method of claim 1 , wherein the flowing the flowing blood in the headspace includes flowing blood from the blood part into the headspace and the flowing dilution fluid in the headspace is effective to post-dilute blood passing from the blood part.

4. The method of claim 1 , wherein the flowing dilution fluid is at such a velocity and direction that swirling of the blood and dilution fluid occurs in the headspace.

5. The method of claim 1 , wherein the headspace is circular and the flowing dilution fluid includes directing dilution fluid in a tangential flow path in the headspace.

6. The method of claim 1 , wherein the blood flowing in the headspace is thoroughly mixed with the dilution fluid in the headspace.

7. The method of claim 1 , the flowing dilution fluid includes sweeping particles of thrombus in the headspace.

8. The method of claim 1 , wherein the dilution fluid is a physiological fluid containing at least one of saline and lactate.

9. The method of claim 1 , wherein the filter media includes filter fibers with ends, the headspace lying between the ends of the filter fibers and the cap.

10. The method of claim 1 , wherein the headspace has a depth of not more than 3 mm between the filter media and the cap.

11. The method of claim 1 , wherein the headspace has an internal shape and size for minimizing formation of blood clots.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2019
From: CAPITAL ONE, NATIONAL ASSOCIATION (AS SUCCESSOR BY MERGER TO HEALTHCARE FINANCIAL SOLUTIONS, LLC)
To: NXSTAGE MEDICAL, INC.
Reel/Frame 048407/0865 →
RELEASE OF SECURITY INTEREST Recorded Jul 28, 2017
From: ASAHI KASEI MEDICAL CO., LTD. F/K/A ASAHI KASEI KURARAY MEDICAL CO., LTD.
To: NXSTAGE MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
Reel/Frame 043364/0936 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037112/0376 →
RELEASE OF SECURITY INTEREST Recorded Jun 11, 2014
From: SILICON VALLEY BANK
To: NXSTAGE MEDICAL, INC.
Reel/Frame 033133/0902 →
SECURITY INTEREST Recorded Jun 10, 2014
From: NXSTAGE MEDICAL, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 033123/0836 →
SECURITY AGREEMENT Recorded Mar 22, 2010
From: NXSTAGE MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 024114/0789 →
RELEASE OF SECURITY INTEREST Recorded Jun 10, 2009
From: GE BUSINESS FINANCIAL SERVICES INC.
To: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
Reel/Frame 022804/0150 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 10, 2009
From: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
To: ASAHI KASEI KURARAY MEDICAL CO., LTD.
Reel/Frame 022804/0496 →
SECURITY AGREEMENT Recorded Apr 7, 2009
From: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
To: GE BUSINESS FINANCIAL SERVICES INC.
Reel/Frame 022610/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2008
From: BRUGGER, JAMES M.; BURBANK, JEFFREY H.; STILLIG, MARTIN
To: NXSTAGE MEDICAL, INC.
Reel/Frame 020562/0792 →